Neoadjuvant pembrolizumab achieved 71% pathologic complete response in desmoplastic melanoma patients, while lower-dose ipilimumab combination therapy showed improved survival and fewer side effects in advanced melanoma treatment.
New research and precision radiation techniques aim to minimize debilitating side effects of head and neck cancer treatment, including oral mucositis, while maintaining tumor control and improving patient quality of life.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07053969 |
The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness |
RECRUITING | NA |
| NCT06725095 |
Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis |
ENROLLING_BY_INVITATION | NA |
| NCT06599346 |
Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients |
RECRUITING | NA |
| NCT06521112 |
The Effect of Oral Care on Mucositis and Oral Mucosa According to Individual Oral Care Frequency Assessment |
COMPLETED | NA |
| NCT06481254 |
Effect of Hawthorn Vinegar, Black Mulberry Syrup and Green Tea on Oral Mucositis |
COMPLETED | NA |
| NCT06472024 |
Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study |
NOT_YET_RECRUITING | NA |
| NCT06117904 |
Adjunctive Treatments for the Prevention of Radiotherapy-Induced Mucositis |
COMPLETED | NA |
| NCT05849415 |
Periodontal Health and Its Relationship With Psychological Stress |
COMPLETED | |
| NCT05669521 |
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690 |
UNKNOWN | PHASE2 |
| NCT05658016 |
Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690 |
UNKNOWN | PHASE2 |
